JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riou, L. M.
Right arrow Articles by Glover, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riou, L. M.
Right arrow Articles by Glover, D. K.
Journal of Nuclear Medicine Vol. 44 No. 7 1092-1098
© 2003 by Society of Nuclear Medicine


Basic Science Investigations

Effects of Increased Lipid Concentration and Hyperemic Blood Flow on the Intrinsic Myocardial Washout Kinetics of 99mTcN-NOET

Laurent M. Riou, PhD, Steve Unger, MD, Marie-Claire Toufektsian, PhD, Mirta Ruiz, MD, Denny D. Watson, PhD, George A. Beller, MD and David K. Glover, ME

Cardiovascular Division, University of Virginia Health System, Charlottesville, Virginia

Bis(N-ethoxy,N-ethyldithiocarbamato)nitrido technetium (V) (99mTc) (99mTcN-NOET) is a myocardial perfusion imaging agent demonstrating significant redistribution and currently in phase III clinical trials. Previous studies have suggested that 99mTcN-NOET is bound intravascularly. Therefore, we sought to determine whether modifications in the vascular compartment would provide further insights into the mechanisms of 99mTcN-NOET myocardial washout and redistribution. Methods:99mTcN-NOET cardiac washout was studied ex vivo in 15 isolated perfused rat hearts after bolus injection (1.5 MBq) in the absence (n = 6) or presence of bovine serum albumin ([BSA] 0.03%) with (n = 5) or without (n = 4) bound lipids. The intrinsic myocardial washout of the tracer was also studied in vivo in 6 dogs after intracoronary bolus injection of the tracer (0.75 MBq) before and after hyperlipidemia induced by intravenous administration of 300 mL of 20% intralipids (n = 3) or hyperemia induced by intravenous infusion of the adenosine A2A receptor agonist ATL-146e (0.3 µg/kg/min; n = 6). Results: On isolated hearts, there was no significant myocardial washout of 99mTcN-NOET with Krebs–Henseleit buffer. Addition of BSA without bound lipids resulted in a significant cardiac washout of the tracer (P < 0.001 by repeated measures ANOVA). The presence of lipids bound to BSA further accelerated the washout rate of 99mTcN-NOET (half-life [t1/2], 431.5 ± 23.2 min vs. 242.9 ± 63.2 min; P < 0.05). In vivo in dogs, intralipid administration significantly increased the intrinsic washout rate of 99mTcN-NOET (t1/2, 108.0 ± 23.9 min vs. 51.8 ± 11.8 min; P < 0.05). In addition, vasodilatation with ATL-146e resulted in a 4.9-fold increase in coronary flow (P < 0.05 vs. baseline) and a significantly faster intrinsic 99mTcN-NOET myocardial washout (t1/2, 81.1 ± 12.1 min vs. 40.7 ± 7.3 min; P < 0.05). Conclusion: The myocardial washout kinetics of 99mTcN-NOET are affected by a variety of intravascular factors, supporting the hypothesis that the tracer is most likely localized on the vascular endothelium. The potential impact of variations in circulating lipid levels among patients on clinical imaging with 99mTcN-NOET requires further investigation.

Key Words: bis(N-ethoxy,N-ethyldithiocarbamato)nitrido technetium (V) (99mTc) • myocardial kinetics • lipids • redistribution • mechanisms







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.